𝗕𝗦𝗙 𝗘𝗻𝘁𝗲𝗿𝗽𝗿𝗶𝘀𝗲 𝗣𝗟𝗖 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝘀 𝗻𝗲𝘄 𝗰𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝗮𝗴𝗿𝗲𝗲𝗺𝗲𝗻𝘁 𝗶𝗻 𝗰𝘂𝗹𝘁𝗶𝘃𝗮𝘁𝗲𝗱 𝗺𝗲𝗮𝘁 𝗕𝗦𝗙 𝗘𝗻𝘁𝗲𝗿𝗽𝗿𝗶𝘀𝗲 𝗣𝗟𝗖 has announced that its subsidiary 𝟯𝗗 𝗕𝗶𝗼-𝗧𝗶𝘀𝘀𝘂𝗲𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 (𝟯𝗗𝗕𝗧) has signed a 𝗳𝗶𝘃𝗲-𝘆𝗲𝗮𝗿 commercial supply agreement with 𝗦𝗲𝗮𝗪𝗶𝘁𝗵, a biotechnology company focused on cultivated meat. This agreement marks a clear step forward in the commercial rollout of 𝗖𝗶𝘁𝘆-𝗠𝗶𝘅®, 𝟯𝗗𝗕𝗧’s proprietary cell culture additive. What this means: 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝘁𝗿𝗮𝗰𝘁𝗶𝗼𝗻 City-Mix® moves further into the global cultivated protein market 𝗥𝗲𝘃𝗲𝗻𝘂𝗲 𝘃𝗶𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝘆 Approx. £300,000 contract value over five years 𝗥𝗲𝗮𝗹-𝘄𝗼𝗿𝗹𝗱 𝗮𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 Supporting production of SeaWith’s Welldone™ cultivated beef 𝗖𝗼𝘀𝘁 𝗿𝗲𝗱𝘂𝗰𝘁𝗶𝗼𝗻 Up to 30% less reliance on expensive growth media 𝗦𝗰𝗮𝗹𝗲 𝗽𝗮𝘁𝗵𝘄𝗮𝘆 Supply volumes expected to grow alongside commercial production through 2030 This is not early-stage research. This is deployment into an active production pipeline. For 𝗕𝗦𝗙 𝗘𝗻𝘁𝗲𝗿𝗽𝗿𝗶𝘀𝗲, it reinforces a clear strategy: • Build enabling technologies • Partner with producers • Scale through commercial supply agreements The cultivated meat sector needs cost reduction to unlock scale. City-Mix® is now positioned as part of that solution. How quickly do you think cost efficiencies like this will accelerate market adoption? Check out the full announcement and join in with the conversation at: bsfenterprise.com/link/Pqnkoy #BSFE #BSFA #BSFAF #CultivatedMeat #Biotech #CellCulture #FoodTech #Innovation
